Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells
Authors
Keywords
-
Journal
Cellular & Molecular Immunology
Volume 18, Issue 1, Pages 112-127
Publisher
Springer Science and Business Media LLC
Online
2020-11-24
DOI
10.1038/s41423-020-00572-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma
- (2020) Ann-Lii Cheng et al. JOURNAL OF HEPATOLOGY
- ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
- (2020) John Alec Moral et al. NATURE
- Neutrophils as emerging therapeutic targets
- (2020) Tamás Németh et al. NATURE REVIEWS DRUG DISCOVERY
- VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance
- (2020) Mohamed A. ElTanbouly et al. SCIENCE
- Hepatic ILC2 activity is regulated by liver inflammation-induced cytokines and effector CD4+ T cells
- (2020) Silja Steinmann et al. Scientific Reports
- A phase Ib study of lenvatinib (LEN) plus pembrolizumab (PEMBRO) in unresectable hepatocellular carcinoma (uHCC).
- (2020) Andrew X. Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of γδT cells in liver diseases and its relationship with intestinal microbiota
- (2020) Qi-Hui Zhou et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Natural Killer Cell Responses in Hepatocellular Carcinoma: Implications for Novel Immunotherapeutic Approaches
- (2020) Stefania Mantovani et al. Cancers
- Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes
- (2020) Di Cao et al. Aging-US
- P-347 A phase 3, randomized, double-blind, placebo-controlled study of transarterial chemoembolization combined with durvalumab or durvalumab plus bevacizumab therapy in patients with locoregional hepatocellular carcinoma: EMERALD-1
- (2020) B. Sangro et al. ANNALS OF ONCOLOGY
- Cancer immunotherapy with γδ T cells: many paths ahead of us
- (2020) Dieter Kabelitz et al. Cellular & Molecular Immunology
- Ligand recognition by the γδ TCR and discrimination between homeostasis and stress conditions
- (2020) Malte Deseke et al. Cellular & Molecular Immunology
- Intratumoral γδ T‐cell infiltrates, CCL4/5 protein expression and survival in patients with hepatocellular carcinoma
- (2020) Na Zhao et al. HEPATOLOGY
- Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies
- (2020) Tobias Bald et al. NATURE IMMUNOLOGY
- Increased both PD–L1 and PD–L2 expressions on monocytes of patients with hepatocellular carcinoma was associated with a poor prognosis
- (2020) Hidetaka Yasuoka et al. Scientific Reports
- Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia
- (2020) Meir Rozenbaum et al. Frontiers in Immunology
- Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma
- (2020) Furong Liu et al. Experimental Hematology & Oncology
- Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Andrew X Zhu et al. LANCET ONCOLOGY
- Phase 1 Trial With the Cell-Based Immune Primer Ilixadencel, Alone, and Combined With Sorafenib, in Advanced Hepatocellular Carcinoma
- (2019) Magnus Rizell et al. Frontiers in Oncology
- Broad Cytotoxic Targeting of Acute Myeloid Leukemia by Polyclonal Delta One T Cells
- (2019) Biagio Di Lorenzo et al. Cancer Immunology Research
- CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4+ T-Cell–Dependent Control of Senescence
- (2019) Jana C. Mossanen et al. GASTROENTEROLOGY
- Activated and Exhausted MAIT Cells Foster Disease Progression and Indicate Poor Outcome in Hepatocellular Carcinoma
- (2019) Meng Duan et al. CLINICAL CANCER RESEARCH
- Commensal Microbiota Promote Lung Cancer Development via γδ T Cells
- (2019) Chengcheng Jin et al. CELL
- RATIONALE 301 study: tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma
- (2019) Shukui Qin et al. Future Oncology
- Nivolumab (NIVO) + ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040.
- (2019) Thomas Yau et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 3 (COSMIC-312) study of cabozantinib (C) in combination with atezolizumab (A) versus sorafenib (S) in patients (pts) with advanced hepatocellular carcinoma (aHCC) who have not received previous systemic anticancer therapy.
- (2019) Robin Kate Kelley et al. JOURNAL OF CLINICAL ONCOLOGY
- Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
- (2019) Mohsen Malehmir et al. NATURE MEDICINE
- From NASH to HCC: current concepts and future challenges
- (2019) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Hide and seek: Plasticity of innate lymphoid cells in cancer
- (2019) Tobias Bald et al. SEMINARS IN IMMUNOLOGY
- Cancer Immunoediting by Innate Lymphoid Cells
- (2019) Marek Wagner et al. TRENDS IN IMMUNOLOGY
- P-187A phase 3 study of durvalumab with or without bevacizumab as adjuvant therapy in patients with hepatocellular carcinoma (HCC) who are at high risk of recurrence after curative hepatic resection
- (2019) J Knox et al. ANNALS OF ONCOLOGY
- Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
- (2019) Laurent Gauthier et al. CELL
- Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas
- (2019) Qi Zhang et al. GUT
- Chronically stimulated human MAIT cells are unexpectedly potent IL‐13 producers
- (2019) Jason Kelly et al. IMMUNOLOGY AND CELL BIOLOGY
- Tumour-associated neutrophils in patients with cancer
- (2019) Merav E. Shaul et al. Nature Reviews Clinical Oncology
- Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma
- (2019) Ashanty M. Melo et al. Frontiers in Immunology
- Hepatic Tumor Microenvironments and Effects on NK Cell Phenotype and Function
- (2019) Julián Piñeiro Fernández et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies
- (2019) Zsolt Sebestyen et al. NATURE REVIEWS DRUG DISCOVERY
- Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2019) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- LBA38_PRCheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC)
- (2019) T Yau et al. ANNALS OF ONCOLOGY
- Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma
- (2019) Qiming Zhang et al. CELL
- Differential Modulation of Human Innate Lymphoid Cell (ILC) Subsets by IL-10 and TGF-β
- (2019) Sandra Bonne-Année et al. Scientific Reports
- Type 1 Innate Lymphoid Cells Protect Mice from Acute Liver Injury via Interferon-γ Secretion for Upregulating Bcl-xL Expression in Hepatocytes
- (2019) Tsukasa Nabekura et al. IMMUNITY
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- MAIT Cells Promote Tumor Initiation, Growth, and Metastases via Tumor MR1
- (2019) Juming Yan et al. Cancer Discovery
- Activated innate lymphoid cell populations accumulate in human tumour tissues
- (2018) Maryam Salimi et al. BMC CANCER
- NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
- (2018) Jan P. Böttcher et al. CELL
- Therapeutic Immune Modulation Against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial
- (2018) Chrisann Kyi et al. CLINICAL CANCER RESEARCH
- Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification
- (2018) Yutaka Kurebayashi et al. HEPATOLOGY
- The Immune Landscape of Cancer
- (2018) Vésteinn Thorsson et al. IMMUNITY
- Innate Lymphoid Cells: Diversity, Plasticity, and Unique Functions in Immunity
- (2018) Marco Colonna IMMUNITY
- Human blood MAIT cell subsets defined using MR1 tetramers
- (2018) Nicholas A Gherardin et al. IMMUNOLOGY AND CELL BIOLOGY
- Human liver infiltrating γδ T cells are composed of clonally expanded circulating and tissue-resident populations
- (2018) Stuart Hunter et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- The immunology of hepatocellular carcinoma
- (2018) Marc Ringelhan et al. NATURE IMMUNOLOGY
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
- (2018) Kevin C. Barry et al. NATURE MEDICINE
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
- (2018) Chi Ma et al. SCIENCE
- Personalized vaccines for cancer immunotherapy
- (2018) Ugur Sahin et al. SCIENCE
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- A CS1-NKG2D Bispecific Antibody Collectively Activates Cytolytic Immune Cells against Multiple Myeloma
- (2018) Wing Keung Chan et al. Cancer Immunology Research
- Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer
- (2018) Timm Hoeres et al. Frontiers in Immunology
- γδ T cells in liver diseases
- (2018) Xuefu Wang et al. Frontiers of Medicine
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up
- (2018) Jeong-Hoon Lee et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Innate Lymphoid Cells: 10 Years On
- (2018) Eric Vivier et al. CELL
- A randomized, multicenter phase 3 study of durvalumab (D) and tremelimumab (T) as first-line treatment in patients with unresectable hepatocellular carcinoma (HCC): HIMALAYA study.
- (2018) Ghassan K. Abou-Alfa et al. JOURNAL OF CLINICAL ONCOLOGY
- 209TiPCA209-9DX: Phase III, randomized, double-blind study of adjuvant nivolumab vs placebo for patients with hepatocellular carcinoma (HCC) at high risk of recurrence after curative resection or ablation
- (2018) M J Jimenez Exposito et al. ANNALS OF ONCOLOGY
- Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells
- (2018) Patrick L. Collins et al. CELL
- High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice
- (2018) Adeline Crinier et al. IMMUNITY
- Cancer immunoediting and resistance to T cell-based immunotherapy
- (2018) Jake S. O’Donnell et al. Nature Reviews Clinical Oncology
- Association Between High-Avidity T-Cell Receptors, Induced by α-Fetoprotein−Derived Peptides, and Anti-Tumor Effects in Patients With Hepatocellular Carcinoma
- (2017) Hidetoshi Nakagawa et al. GASTROENTEROLOGY
- Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway
- (2017) Ting-ting Wang et al. GUT
- Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study
- (2017) Hans J. Hammers et al. JOURNAL OF CLINICAL ONCOLOGY
- Personalized treatment of patients with very early hepatocellular carcinoma
- (2017) Alessandro Vitale et al. JOURNAL OF HEPATOLOGY
- Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
- (2017) Austin G. Duffy et al. JOURNAL OF HEPATOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- The role of Kupffer cells in hepatic diseases
- (2017) Peizhi Li et al. MOLECULAR IMMUNOLOGY
- The immune contexture in cancer prognosis and treatment
- (2017) Wolf H. Fridman et al. Nature Reviews Clinical Oncology
- Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy
- (2017) Zachary B. Davis et al. SEMINARS IN IMMUNOLOGY
- Chimeric antigen receptor–engineered natural killer and natural killer T cells for cancer immunotherapy
- (2017) Dominique Bollino et al. Translational Research
- Platelet-derived growth factor receptor α in hepatocellular carcinoma is a prognostic marker independent of underlying liver cirrhosis
- (2017) Jung-Hwan Yu et al. Oncotarget
- Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma
- (2017) Nicola Personeni et al. Oncotarget
- Neutrophil count is associated with myeloid derived suppressor cell level and presents prognostic value for hepatocellular carcinoma patients
- (2017) Xing Li et al. Oncotarget
- Anti-tumor Activity of Toll-Like Receptor 7 Agonists
- (2017) Huju Chi et al. Frontiers in Pharmacology
- Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
- (2017) Congcong Zhang et al. Frontiers in Immunology
- Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer
- (2017) S. Meraviglia et al. OncoImmunology
- A Natural CCR2 Antagonist Relieves Tumor-associated Macrophage-mediated Immunosuppression to Produce a Therapeutic Effect for Liver Cancer
- (2017) Wenbo Yao et al. EBioMedicine
- Mechanisms Balancing Tolerance and Immunity in the Liver
- (2017) Jan P. Böttcher et al. DIGESTIVE DISEASES
- Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression
- (2016) Tobias Eggert et al. CANCER CELL
- Emerging Opportunities and Challenges in Cancer Immunotherapy
- (2016) T. L. Whiteside et al. CLINICAL CANCER RESEARCH
- IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
- (2016) D. A. Vallera et al. CLINICAL CANCER RESEARCH
- Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib
- (2016) Shao-Lai Zhou et al. GASTROENTEROLOGY
- Chemokine (C-C motif) receptor 2-positive monocytes aggravate the early phase of acetaminophen-induced acute liver injury
- (2016) Jana C. Mossanen et al. HEPATOLOGY
- A new HIF-1α/RANTES-driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1/HAF in mice
- (2016) Mei Yee Koh et al. HEPATOLOGY
- Expansion and Activation of CD103 + Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
- (2016) Hélène Salmon et al. IMMUNITY
- Targeting T Cell Co-receptors for Cancer Therapy
- (2016) Margaret K. Callahan et al. IMMUNITY
- Activation strategies for invariant natural killer T cells
- (2016) Ayano C. Kohlgruber et al. IMMUNOGENETICS
- Human liver-resident CD56bright/CD16neg NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways
- (2016) Kelly Hudspeth et al. JOURNAL OF AUTOIMMUNITY
- A Proinflammatory Role of Type 2 Innate Lymphoid Cells in Murine Immune-Mediated Hepatitis
- (2016) Katrin Neumann et al. JOURNAL OF IMMUNOLOGY
- Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis
- (2016) Christoph S N Klose et al. NATURE IMMUNOLOGY
- Development of immuno-oncology drugs — from CTLA4 to PD1 to the next generations
- (2016) Axel Hoos NATURE REVIEWS DRUG DISCOVERY
- Immunology in the liver — from homeostasis to disease
- (2016) Felix Heymann et al. Nature Reviews Gastroenterology & Hepatology
- Human Vδ2 T cells are a major source of interleukin-9
- (2016) Christian Peters et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dendritic cell-elicited B-cell activation fosters immune privilege via IL-10 signals in hepatocellular carcinoma
- (2016) Fang-Zhu Ouyang et al. Nature Communications
- Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma
- (2016) Guohe Lin et al. Oncotarget
- Novel TGF-β inhibitors ready for prime time in onco-immunology
- (2016) Armand de Gramont et al. OncoImmunology
- CXCR6 marks a novel subset of T-betloEomeshi natural killer cells residing in human liver
- (2016) Kerstin A. Stegmann et al. Scientific Reports
- Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients
- (2015) Luciane Zabijak et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Emerging Protumor Role of T Lymphocytes: Implications for Cancer Immunotherapy
- (2015) M. Rei et al. CANCER RESEARCH
- Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
- (2015) Joon Hyeok Lee et al. GASTROENTEROLOGY
- Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma
- (2015) Xiaoguang Li et al. GUT
- Myeloid cells in hepatocellular carcinoma
- (2015) Shanshan Wan et al. HEPATOLOGY
- The biliary epithelium presents antigens to and activates natural killer T cells
- (2015) Elisabeth Schrumpf et al. HEPATOLOGY
- Liver inflammation abrogates immunological tolerance induced by Kupffer cells
- (2015) Felix Heymann et al. HEPATOLOGY
- Tissue-Specific Distribution of iNKT Cells Impacts Their Cytokine Response
- (2015) You Jeong Lee et al. IMMUNITY
- Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
- (2015) Douglas Marvel et al. JOURNAL OF CLINICAL INVESTIGATION
- A dynamic spectrum of monocytes arising from the in situ reprogramming of CCR2+monocytes at a site of sterile injury
- (2015) Daniela Dal-Secco et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma
- (2015) Oscar W.H. Yeung et al. JOURNAL OF HEPATOLOGY
- Cell therapy for liver disease: From liver transplantation to cell factory
- (2015) Stuart J. Forbes et al. JOURNAL OF HEPATOLOGY
- Human Mucosa-Associated Invariant T Cells Accumulate in Colon Adenocarcinomas but Produce Reduced Amounts of IFN-γ
- (2015) Patrik Sundström et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Identification and Characterization of Human Intrahepatic CD49a+NK Cells
- (2015) Nicole Marquardt et al. JOURNAL OF IMMUNOLOGY
- The biology of innate lymphoid cells
- (2015) David Artis et al. NATURE
- Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma
- (2015) Shlomi Finkin et al. NATURE IMMUNOLOGY
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- Immunological landscape and immunotherapy of hepatocellular carcinoma
- (2015) Jesús Prieto et al. Nature Reviews Gastroenterology & Hepatology
- Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma
- (2015) Longhao Sun et al. TUMOR BIOLOGY
- Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells
- (2015) A. R. Sanchez-Paulete et al. Cancer Discovery
- Tumor-infiltrating plasmacytoid dendritic cells promote immunosuppression by Tr1 cells in human liver tumors
- (2015) Alexander Pedroza-Gonzalez et al. OncoImmunology
- Low Counts of γδ T Cells in Peritumoral Liver Tissue are Related to More Frequent Recurrence in Patients with Hepatocellular Carcinoma after Curative Resection
- (2014) Xiao-Yan Cai et al. Asian Pacific Journal of Cancer Prevention
- Human innate lymphoid cells
- (2014) M. D. Hazenberg et al. BLOOD
- Metabolic Activation of Intrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes
- (2014) Monika Julia Wolf et al. CANCER CELL
- Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
- (2014) Miranda L. Broz et al. CANCER CELL
- IL-17A Produced by T Cells Promotes Tumor Growth in Hepatocellular Carcinoma
- (2014) S. Ma et al. CANCER RESEARCH
- Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells
- (2014) Shanshan Wan et al. GASTROENTEROLOGY
- Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy
- (2014) Takeshi Terashima et al. HEPATOLOGY RESEARCH
- γδT17 Cells Promote the Accumulation and Expansion of Myeloid-Derived Suppressor Cells in Human Colorectal Cancer
- (2014) Pin Wu et al. IMMUNITY
- Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes
- (2014) YU SAWADA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Macrophage heterogeneity in liver injury and fibrosis
- (2014) Frank Tacke et al. JOURNAL OF HEPATOLOGY
- γδT Cells Drive Myeloid-Derived Suppressor Cell–Mediated CD8+T Cell Exhaustion in Hepatitis B Virus–Induced Immunotolerance
- (2014) Xiaohui Kong et al. JOURNAL OF IMMUNOLOGY
- γ/δ T cell subsets in human aging using the classical α/β T cell model
- (2014) Anusha Vasudev et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Hepatitis B virus infection
- (2014) Christian Trépo et al. LANCET
- MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets
- (2014) A Kurioka et al. Mucosal Immunology
- Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors
- (2014) Elisa Gomez Perdiguero et al. NATURE
- T-cell activation by transitory neo-antigens derived from distinct microbial pathways
- (2014) Alexandra J. Corbett et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Tumor-Associated Neutrophils as a New Prognostic Factor in Cancer: A Systematic Review and Meta-Analysis
- (2014) Meixiao Shen et al. PLoS One
- Gamma Delta T-lymphocytes in Hepatitis C and Chronic Liver Disease
- (2014) Neil Rajoriya et al. Frontiers in Immunology
- The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
- (2013) Miriam Merad et al. Annual Review of Immunology
- Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
- (2013) Eric O. Long et al. Annual Review of Immunology
- Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
- (2013) Ivan P. Jovanovic et al. INTERNATIONAL JOURNAL OF CANCER
- A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocelluar carcinoma
- (2013) Xiaozhou Yu et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells
- (2013) Rangsima Reantragoon et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
- (2013) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- Chemokine Receptor CXCR6-Dependent Hepatic NK T Cell Accumulation Promotes Inflammation and Liver Fibrosis
- (2013) A. Wehr et al. JOURNAL OF IMMUNOLOGY
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
- (2013) Jeong Heo et al. NATURE MEDICINE
- Natural Cytotoxicity Receptors: Broader Expression Patterns and Functions in Innate and Adaptive Immune Cells
- (2013) Kelly Hudspeth et al. Frontiers in Immunology
- Tumor cell recognition by γδ T lymphocytes
- (2013) Daniel V. Correia et al. OncoImmunology
- A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma
- (2012) Tim F Greten et al. BMC CANCER
- CXCR6 Upregulation Contributes to a Proinflammatory Tumor Microenvironment That Drives Metastasis and Poor Patient Outcomes in Hepatocellular Carcinoma
- (2012) Q. Gao et al. CANCER RESEARCH
- Phase I Trial of a Glypican-3-Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
- (2012) Y. Sawada et al. CLINICAL CANCER RESEARCH
- NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease
- (2012) Wing-Kin Syn et al. GUT
- Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma
- (2012) Shao-Lai Zhou et al. HEPATOLOGY
- Fibrosis-dependent mechanisms of hepatocarcinogenesis
- (2012) David Y. Zhang et al. HEPATOLOGY
- Natural killer cells in liver disease
- (2012) Zhigang Tian et al. HEPATOLOGY
- Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
- (2012) FUJIMASA TADA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC
- (2012) Mervat El Ansary et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The functional impairment of HCC-infiltrating γδ T cells, partially mediated by regulatory T cells in a TGFβ- and IL-10-dependent manner
- (2012) Yong Yi et al. JOURNAL OF HEPATOLOGY
- NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner
- (2012) Andreas Glässner et al. LABORATORY INVESTIGATION
- MR1 presents microbial vitamin B metabolites to MAIT cells
- (2012) Lars Kjer-Nielsen et al. NATURE
- Characterization of Human γδ T Lymphocytes Infiltrating Primary Malignant Melanomas
- (2012) Adriana Cordova et al. PLoS One
- Differentiation, phenotype, and function of interleukin-17-producing human V 9V 2 T cells
- (2011) N. Caccamo et al. BLOOD
- Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
- (2011) A J Nicol et al. BRITISH JOURNAL OF CANCER
- Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO
- (2011) Tuanjie Li et al. CANCER LETTERS
- Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
- (2011) Bin Gao et al. GASTROENTEROLOGY
- Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma
- (2011) Valerie Chew et al. GUT
- Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function
- (2011) James A. Thomas et al. HEPATOLOGY
- Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report
- (2011) Pierre-Alain Clavien et al. LANCET ONCOLOGY
- Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
- (2011) Tae-Won Kang et al. NATURE
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells
- (2010) M. Dusseaux et al. BLOOD
- Elevation of activated γδ T cell receptor bearing T lymphocytes in patients with autoimmune chronic liver disease
- (2010) L. WEN et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy
- (2010) Kazuki Yamasaki et al. CLINICAL IMMUNOLOGY
- Promoting angiogenesis within the tumor microenvironment: The secret life of murine lymphoid IL-17-producing γδ T cells
- (2010) Bruno Silva-Santos EUROPEAN JOURNAL OF IMMUNOLOGY
- Tolerogenic plasmacytoid DC
- (2010) Benjamin M. Matta et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease
- (2010) Wing-Kin Syn et al. HEPATOLOGY
- Intratumoral neutrophils: A poor prognostic factor for hepatocellular carcinoma following resection
- (2010) Yi-Wei Li et al. JOURNAL OF HEPATOLOGY
- Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma
- (2010) Dong-Ming Kuang et al. JOURNAL OF HEPATOLOGY
- Cytokine Requirements for the Differentiation and Expansion of IL-17A- and IL-22-Producing Human V 2V 2 T Cells
- (2010) K. J. Ness-Schwickerath et al. JOURNAL OF IMMUNOLOGY
- Antimicrobial activity of mucosal-associated invariant T cells
- (2010) Lionel Le Bourhis et al. NATURE IMMUNOLOGY
- iNKT Cells Control Mouse Spontaneous Carcinoma Independently of Tumor-Specific Cytotoxic T Cells
- (2010) Matteo Bellone et al. PLoS One
- Type I natural killer T cells suppress tumors caused by p53 loss in mice
- (2009) J. B. Swann et al. BLOOD
- Kupffer Cell Suppression of CD8+ T Cells in Human Hepatocellular Carcinoma Is Mediated by B7-H1/Programmed Death-1 Interactions
- (2009) K. Wu et al. CANCER RESEARCH
- Combination therapy ofin vitro-expanded natural killer T cells and α-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma
- (2009) Naoki Kunii et al. CANCER SCIENCE
- Toll-like receptors as targets in chronic liver diseases
- (2009) A Mencin et al. GUT
- Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor
- (2009) Bastian Hoechst et al. HEPATOLOGY
- Hepatic recruitment of the inflammatory Gr1+monocyte subset upon liver injury promotes hepatic fibrosis
- (2009) Karlin Raja Karlmark et al. HEPATOLOGY
- Enrichment of Human CD4+ V 24/V 11 Invariant NKT Cells in Intrahepatic Malignant Tumors
- (2009) G. Bricard et al. JOURNAL OF IMMUNOLOGY
- Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma
- (2008) D. Y. Chiang et al. CANCER RESEARCH
- Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients
- (2008) Lun Cai et al. CLINICAL IMMUNOLOGY
- A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells
- (2008) Bastian Hoechst et al. GASTROENTEROLOGY
- A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma
- (2008) Daniel H. Palmer et al. HEPATOLOGY
- High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection
- (2008) Tong Ding et al. HUMAN PATHOLOGY
- TLR-dependent cross talk between human Kupffer cells and NK cells
- (2008) Zhengkun Tu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Natural killer cell recognition of missing self
- (2008) Klas Kärre NATURE IMMUNOLOGY
- Up on the tightrope: natural killer cell activation and inhibition
- (2008) Lewis L Lanier NATURE IMMUNOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity
- (2008) K. Hildner et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now